Skip to main content

Artificial Intelligence and Health Technologies in Cardiovascular Disease 2023

Type of event


Dear Colleagues

Artificial intelligence and digital health are rapidly evolving disciplines and will be transforming healthcare. Applications of AI in cardiovascular medicine are machine learning techniques for diagnostic procedures including imaging modalities and biomarkers and predictive analytics for personalised therapies and improved outcomes. Fields of application include genetics, cardiomyopathy, valve disease, GUCH, cardiac pathology and many more.

We have brought together key opinion leaders and recognised experts in the field of AI to provide an insight on their experience, new applications and the impact of AI on future clinical decision making.

The target audience are cardiologists, oncologists, cardiac surgeons, internists, endocrinologists as well as imaging and device specialists from clinics and industry.

We would be happy to virtually welcome you on September 20th-21st this year and look forward to seeing you.

With best regards, Yours sincerely,

Charalambos Antoniades

Alexander Lyon

Alan Maisel

Thomas F. Lüscher



WEDNESDAY, September 20th, 2023, UK Time

16:00 - 19:00 | SESSION 1: OPENING SESSION
Chairs: Charalambos Antoniades and Alan Maisel
16:00-16:10 Welcome and introduction T.F. Lüscher, London
16:10-16:30 AI in cardiovascular medicine: Update 2023 P. Friedman, Rochester
16:30-16:40 Q&A  
16:40-17:00 Wearable tools to diagnose arrhythmias A. Bauer, Innsbruck
17:00-17:10 Q&A  
17:10-17:30 Data science and AI in cardiovascular imaging P. Leeson, Oxford
17:30-17:40 Q&A  
17:40-18:00 The marriage of biomarkers and machine learning in acute CVD A.S. Maisel, San Diego
18:00-18:10 Q&A  
18:10-18:30 Wearable cardiac ultrasound imager: a new frontier    S. Xu, San Diego
18:30-18:40 Q&A  
18:45-19:00 Wrap Up Session 1  


THURSDAY, September 21st, 2023, UK time

Chairs: Thomas F. Lüscher and Charalambos Antoniades
09:00-9:15 Using AI to predict CV risk from routine CT C. Antoniades, Oxford
09:15-09:20 Q&A  
09:20-09:35 Machine learning-based prediction of  in-hospital death for patients with Tako-Tsubo Syndrome
(2020 Acute Coronary Syndromes (ACS) in Patients Presenting without Persistent ST-Segment Elevation (Management of) Guidelines)
O. De Filippo, Turin
09:35-09:40 Q&A  
09:40-09:55 Risk prediction in the acute setting in males and females with NSTE-ACS: The Grace 3 Score
(2020 Acute Coronary Syndromes (ACS) in Patients Presenting without Persistent ST-Segment Elevation (Management of) Guidelines)
F. Wenzl, Zurich
09:55-10:00 Q&A  
10:00-10:15 The future of digital tools for outcome prediction D. Kotecha, Birmingham
10:15-10:20 Q&A  
10:20-10:30 Wrap Up Session 2  
10:30 - 11:00  COFFEE BREAK  


Chairs: John E. Deanfield and Emma Svennberg
11:00-11:15 Polygenic risk scores or machine learning in predicting coronary artery disease status H. Schunkert, Munich
11:15-11:20 Q&A  
11:20-11:35 Proteomics-enabled deep learning machine algorithms can enhance prediction of mortality K.-P. Kresoja, Leipzig
11:35-11:40 Q&A  
11:40-11:55 Integrating fundamental discovery and translation with clinical care using AI    C. Macrae, Boston   
11:55-12:00 Q&A  
12:00-12:10 Wrap Up Session 3  
12:15 - 13:15  LUNCH BREAK  


Chairs: Charalambos Antoniades and Thomas F. Lüscher
13:15-13:30 AI to phenotype adipose tissue and cardiometabolic disease E. Oikonomou, New Haven
13:30-13:35 Q&A  
13:35-13:50 AI to measure coronary artery flow J. Moon, London
13:50-13:55 Q&A  
13:55-14:10 AI as a diagnostic tool for valve disease
(2021 ESC/EACTS Guidelines for the management of valvular heart disease)
J.J. Bax, Leiden
14:10-14:15 Q&A  
14:15-14:30 Medical value and use of digital algorithms in decision making support S. Blankenberg, Hamburg
14:30-14:35 Q&A  
14:35-14:45 Wrap Up Session 4  
14:45 - 15:15 COFFEE BREAK  


Chairs:Thomas F. Lüscher and Alan Maisel
15:15-15:30 How to include AI in secondary prevention
(2021 ESC Guidelines on cardiovascular disease prevention in clinical practice)
F. Asselbergs, Amsterdam
15:30-15:35 Q&A  
15:35-15:50 Ethics and digital health tools E. Caiani, Milan
15:50-15:55 Q&A  
15:55-16:10 AI in the diagnosis and management of arrhythmia E. Svennberg, Stockholm
16:10-16:15 Q&A  
16:15-16:30 AI in transthyretin cardiac amyloidosis: Is it time for clinical application? M. Grogan, Rochester
16:30-16:35 Q&A  
16:35-16:50 New advances in troponin measurements A. Maisel, San Diego
16:50-16:55 Q&A  
16:55-17:00 Wrap Up Session 5  


Teaching Faculty

Charalambos Antoniades
University of Oxford
Oxford, UK

Folkert Asselbergs
Amsterdam Heart Center
Amsterdam, NL

Axel Bauer
University Hospital Innsbruck
Innsbruck, AT

Jeroen J. Bax
Leiden University Medical Center
Leiden, NL

Stefan Blankenberg
University Heart & Vascular Center
Hamburg, DE

Enrico G. Caiani
Politecnico die Milano
Milano, IT

Ovidio De Filippo
University of Turin
Turin, IT

John E. Deanfield
University College London
London, UK

Paul A. Friedman
Mayo Clinic
Rochester, MN, USA

Martha Grogan
Mayo Clinic
Rochester, MN, USA

Dipak Kotecha
University of Birmingham
Birmingham, UK

Karl-Patrik Kresoja
Heart Center of Leipzig
Leipzig, DE

Paul Leeson
John Radcliffe Hospital
Oxford, UK

Thomas F. Lüscher
Royal Brompton and Harefield hospitals
London, UK

Alexander Lyon
Royal Brompton and Harefield hospitals
London, UK

Calum Macrae
Brigham and Women's Hospital
Boston, MA, USA

Alan S. Maisel
VA San Diego Healthcare System
San Diego, CA, USA

James Moon
University College London
London, UK

Evangelos Oikonomou
Yale School of Medicine
New Haven, CT, USA

Heribert Schunkert
German Heart Centre Munich
Munich, DE

Emma Svennberg
Karolinska University Hospital
Stockholm, SE

Florian Wenzl
University of Zurich
Zurich, CH

Sheng Xu
University of California, San Diego
San Diego, CA, USA



Registration (Virtual Event)

Category Fee
Early registration fee (until August 20, 2023)  
Regular fee GBP 105
Residents, students (age<40) GBP 50
Registration fee from August 21, 2023  
Regular fee GBP 115
Residents, students (age<40) GBP 50

Registration will be confirmed upon receipt of payment.

Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.

Modification & Cancellation

All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to Zurich Heart House. For each modification requested by the participant, GBP 15 will be charged for administrative costs. In case of cancellation up to 1st September 2023, deposits will be refunded less 35% for administrative costs. After this date, no refund will be possible.


Zurich Heart House, Foundation for Cardiovascular Research
Dr. Ruth Amstein
Christine Lohmann
Hottingerstrasse 14, CH-8032 Zurich, Switzerland
Phone +41 (0) 44 250 40 83, Fax +41 (0) 44 250 40 90



EACCMEArtificial Intelligence and Health Technologies in Cardiovascular Disease 2023' has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 9 European CME credits (ECMEC®s) and approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 10 category 1 (external) CPD credit(s). 



Event endorsed by

Associated with

In Partnership with

Under the Auspices of